Current status and future perspectives in targeted therapy of NPM1 -mutated AML
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research is being conducted on the current status and future perspectives of targeted therapy for a specific type of cancer, NPM1-mutated AML. Other areas of cancer research are also being explored, including precision medicine, immune checkpoint inhibitor therapy, and gene editing. The broader field of cancer therapy is seeing advancements in various approaches, including microbiota, microbial therapeutics, and exosome-based treatments.
Full coverage
12345678